Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q34431614

about

Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid.Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer.Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.Linifanib--a multi-targeted receptor tyrosine kinase inhibitor and a low molecular weight gelator.Cytotoxic effect of pyocyanin on human pancreatic cancer cell line (Panc-1)

P2860

Q33421322-3E86C645-A908-4E69-87AE-1358513A3266 Q34438516-669A627B-A4D2-4CFE-9821-8AC621EA7DE5 Q37049712-AFE2D3F8-043F-4196-AA3E-FC31AA393FDA Q38666705-AF4A389D-4E70-4F31-A7A6-772845D80151 Q47400861-620FF0B5-D82C-4148-B4BC-A5CA64E90B24 Q58805043-C505FFD2-E005-4269-A30C-A22E24EF922B

P2860

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q34431614

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@ast

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@en

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@nl

type

label

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@ast

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@en

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@nl

prefLabel

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@ast

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@en

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@nl

P1433

Q34431614-4C43B15B-3E28-4551-8ADE-B02E766EE7F0

P1476

Q34431614-8ABBFAB3-7961-4676-8845-E7C62E0F0439

P2093

Q34431614-973576FC-89BC-4AED-A026-C7FF23CAF3F4

Q34431614-AB0894EA-ABF5-477A-9427-1E547510F4A1

P2860

Q34431614-00F143B6-1FF1-4D85-97E4-E51D1C25668C

Q34431614-016DC112-2C03-412D-989B-122D208955BA

Q34431614-0314E8EE-96E7-41CA-B047-41F0A920583D

Q34431614-0838A462-1DEC-4A1E-89BE-1346D7036AFF

Q34431614-0A44F31C-2C93-4D6E-9C04-17224342D05B

Q34431614-0D325C3C-D541-4391-B0A7-F1DD92EB3807

Q34431614-10189555-11E9-4BE2-8F95-C421AB6072C2

Q34431614-14B00C39-F72C-4416-8458-66442579098A

Q34431614-16D6E7D2-0F07-4FEF-9BE4-F1845B083C4C

Q34431614-1B3F5E4D-E22F-4C20-AC76-20B1CE8AFF67

P304

Q34431614-951C80B7-B314-4190-A125-B04547B2AF51

P31

Q34431614-1862872B-69DF-414B-90F1-037FBA45E62A

P356

Q34431614-780D09D9-044A-4540-A3E9-E7DCD930A5AF

P407

Q34431614-3F7C77AB-9D8E-44BB-8E26-FD2F114DA227

P433

Q34431614-D5E6819F-7655-4B72-B5C7-F2E99F4419D5

P478

Q34431614-3BBF30B3-ABDB-4263-9E01-0D8FDA71F943

P577

Q34431614-7BA53375-0729-4ED0-96FC-B53029BBF070

P5875

Q34431614-9D6E254A-E4F2-40A6-A10F-69F77E4AC3C5

P698

Q34431614-391C41E6-53D4-45F2-8394-6DF8907CFBC3

P921

Q34431614-A470BDF7-2A84-4311-AC96-D55215E53916

P356

13543784.2014.933206

P1433

Expert Opinion on Investigational Drugs

P1476

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

@en

P2093

Amal H I Al Haddad

http://www.w3.org/2001/XMLSchema#string

Thomas E Adrian

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

Cancer statistics, 2013

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

Identification of pancreatic cancer stem cells

Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action

Structural and logical analysis of a comprehensive hedgehog signaling pathway to identify alternative drug targets for glioma, colon and pancreatic cancer

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

P304

1499-1515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2014.933206

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264391639

http://www.w3.org/2001/XMLSchema#string

P698

25078674

http://www.w3.org/2001/XMLSchema#string

P921